Starling Oncology, Inc. Common Stock STLN
$4.20
-3.23%
at last close
Analyst Consensus
- Consensus Rating
- Buy (4 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $9.25
- Implied Upside
- +120.2%
- Price Target Range
- $8.00 – $10.00
- Analysts (12 mo)
- 4
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-11-09 | BTIGDavid Larsen |
Reiterates | Buy | $10 |
| 2026-11-06 | Lake Street |
Maintains | Buy | $10 → $8 |
| 2026-11-06 | B. Riley SecuritiesYuan Zhi |
Reiterates | Buy | $11 → $10 |
| 2026-11-06 | BTIGDavid Larsen |
Maintains | Buy | $9 → $10 |
| 2026-10-14 | NeedhamMatthew Shea |
Maintains | Buy | $7 → $9 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $4.20
- Market Cap
- $442.64 million
- 52-Week Range
- $3.35 – $7.13
- Average Volume
- 2.52 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.